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Cl- Chloride ion
CMV Cytomegalovirus
CRP C-reactive protein 
CT Computed tomography
EBV Epstein-Barr virus 
HBO Hyperbaric oxygen
HCO3
- Bicarbonate ion (Hydroxidodioxidocarbonate 1-)
HHV(s) Human herpesvirus(es) 
HHV-6 Human herpesvirus 6
HHV-7 Human herpesvirus 7
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HSV-1 Herpes simplex virus type 1 
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JRP Juvenile recurrent parotitis
K+ Potassium ion
MRI Magnetic resonance imaging
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NSAID Non-steroidal anti-infl ammatory drug
MMP-2 Matrix metalloproteinase 2
MMP-9 Matrix metalloproteinase 9
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In parotitis, one or both of the parotid glands swell, causing pain while eating, reduced 
mouth opening, and in some cases fever. Before the vaccination era, mumps was 
the most common cause of childhood parotitis. Nowadays acute pediatric parotitis 
is rare, and the causative agent(s) are not fully known. It is assumed that other 
viruses in addition to the mumps virus are capable of causing similar symptoms. 
Some children develop recurrent symptoms i.e. juvenile recurrent parotitis (JRP). If 
symptoms are frequent, this condition can be quite life-disruptive. Fortunately, JRP 
often resolves in puberty. The etiology and pathophysiology of this juvenile recurrent 
parotid infl ammation are other aspects currently not completely understood.
The aim of the present study was to assess the epidemiology, etiology, clinical 
picture, and outcome for pediatric parotitis at present. In addition, it addresses 
differential diagnosis and complications. 
A group of 41 children aged ≤17 with acute parotid infl ammation was collected 
prospectively for this study that reported clinical characteristics, treatment, outcome, 
and complications. Another group of 133 children was collected retrospectively with 
the clinical picture of their disease reported, as well. The serine protease inhibitor 
Kazal-type 1 (SPINK-1) genotype was tested in 88 parotitis patients, since mutation 
of this gene disposes to pancreatitis, and salivary glands bear some resemblance to 
the pancreas in function. To map the etiology of parotitis, a questionnaire recarding 
history of parotitis, and parotid gland -related symptoms went to 1,000 adolescents 
randomly selected. In addition, human herpesviruses (HHVs) from saliva samples 
of children with acute parotid infl ammation, and from healthy controls were tested. 
To assess the differential diagnosis and complications of parotitis, the database of 
Helsinki University Central Hospital, Department of Otorhinolaryngology – Head 
and Neck Surgery, was searched according to ICD-10 codes in order to fi nd all 
children diagnosed and treated for osteomyelitis or parotid abscess.
All prospectively studied children with acute parotitis were in good general 
condition, and most episodes of parotitis in childhood seem to run benign curse. 
Half these children were treated only with non-steroidal anti-infl ammatory drugs. 
However, parotid symptoms have a tendency to recur in about half the cases. About 
1% of the respondents to the epidemiologic survey had suffered from parotitis.
Heredity similar to pancreatitis could not be shown, since no difference 
emerged in the SPINK-1 genotype in children with parotitis compared to controls. 
HHVs seem to play no role in acute juvenile parotitis, but are instead common 
fi ndings in saliva. Osteomyelitis of the head and neck region is rare, but important 
in differential diagnosis of children with recurrent parotid symptoms. Parotitis-
related complications are rare. Parotid abscesses are multi-bacterial infections with 
intravenous antibiotic therapy being the cornerstone of treatment. Surgical drainage 
assists in recovery and does not lead to fi stula formation. 
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Abstract
In conclusion, according to this study juvenile parotitis has a frequency close 
to 1%, it has a tendency to recur, and in most cases the overall condition of the 
child is good during the infection. Osteomyelitis as a differential diagnosis must 
be kept in mind when treating recurrent symptoms of the parotid area. Abscesses 
related to parotitis are rare. The full etiology of juvenile parotitis still remains to 
be discovered.
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TIIVISTELMÄ
Korvasylkirauhastulehduksessa poski on kipeä ja turvonnut. Suun aukaiseminen 
on usein rajoittunutta ja syöminen pahentaa kipua. Tautiin voi liittyä kuumetta. 
Ennen kattavia kansallisia rokotuksia sikotauti oli yleinen ja tavallisin korvasylki-
rauhastulehduksen aiheuttaja. Nykyään lasten korvasylkirauhastulehdukset ovat 
harvinaisia eikä kaikkia taudinaiheuttajia tunneta. Sikotautiviruksen lisäksi myös 
muut virukset voivat aiheuttaa korvasylkirauhastulehduksen. Osa lapsista kärsii 
toistuvasta korvasylkirauhastulehduksesta, jonka oireet helpottavat tai häviävät 
yleensä murrosiässä. Myöskään toistuvan korvasylkirauhastulehduksen etiologiaa 
tai patofysiologiaa ei tällä hetkellä tunneta tarkasti.
Tämän väitöskirjatyön tarkoituksena oli selvittää lasten korvasylkirauhastuleh-
dusten epidemiologiaa, etiologiaa, taudin kuvaa ja hoitoa. Lisäksi tutkittiin erotus-
diagnostiikkaa ja komplikaatioita.
Prospektiivinen tutkimusryhmä koostui 41 korvasylkirauhastulehdusta sai-
rastavasta alle 17-vuotiaasta lapsesta. Taudinkuva, hoito ja komplikaatiot selvi-
tettiin. Toinen tutkimusryhmä koostui 133 retrospektiivisesti kerätystä lapsesta, 
joiden taudinkuva ja hoito rekisteröitiin. Seriiniproteaasin estäjä Kazal tyyppi 1:n 
(SPINK-1) genotyyppi testattiin 88 lapselta, koska tiedetään, että tämän geenin 
mutaatiot altistavat haimatulehduksille. Sylkirauhasten ja haiman toiminnassa on 
paljon samankaltaista. Epidemiologian selvittämiseksi tuhannelle satunnaisesti 
valitulle nuorelle lähetettiin kysely sairastetuista korvasylkirauhastulehduksista ja 
muista mahdollisista korvasylkirauhasoireista. Lisäksi korvasylkirauhastulehdusta 
sairastavien lasten, verrokkilasten ja terveiden aikuisverrokkien syljestä testattiin 
herpesviruksia osana etiologisia selvittelyjä. Helsingin yliopistollisen keskussairaa-
lan Silmä-korvasairaalan potilastietokannasta etsittiin kaikki lapset ja nuoret, jotka 
olivat olleet hoidossa pään ja kaulan alueen luutulehduksen tai korvasylkirauhas-
paiseen vuoksi. Pään ja kaulan alueen luutulehduksen ja korvasylkirauhastuleh-
duksen oireet voivat muistuttaa toisiaan, ja paise on korvasylkirauhastulehduksen 
harvinainen komplikaatio.
Kaikkien 41 prospektiivisesti tutkitun lapsen yleistila oli korvasylkirauhastuleh-
duksen aikana hyvä. Suurin osa lasten tulehduksista parantui hyvin, vaikka noin 
puolet lapsista hoidettiin pelkällä tulehduskipulääkityksellä. Noin puolella lapsista 
korvasylkirauhastulehdus uusi. Noin joka sadannella kyselytutkimukseen osallistu-
neesta lapsesta oli ollut korvasylkirauhastulehdus. Tässä tutkimuksessa ei pystytty 
osoittamaan korvasylkirauhastulehduksissa samanlaista SPINK-1 genotyyppiin liit-
tyvää perinnöllisyyttä kuin haimatulehduksissa. Herpesvirukset olivat yleisiä kaik-
kien testiryhmien syljessä, eikä yhteyttä äkilliseen korvasylkirauhastulehdukseen 
löydetty. Pään ja kaulan alueen luutulehdus on harvinainen, mutta tärkeä erotus-
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diagnostinen vaihtoehto. Korvasylkirauhastulehduksiin liittyvät komplikaatiot ovat 
harvinaisia. Korvasylkirauhasen paiseet ovat usean bakteerin aiheuttamia infektioi-
ta, joiden hoidon perusta on suonensisäinen antibioottilääkitys. Paiseen puhkaisu 
tai avaaminen on usein välttämätöntä, eikä johda sylkifi stelin muodostumiseen.
Tämän tutkimuksen perusteella lasten korvasylkirauhastulehdukset ovat luultua 
yleisempiä, niillä on taipumus uusiutua, ja lapsen yleistila on tulehduksen aikana 
yleensä hyvä. Komplikaatiot ovat harvinaisia. Toistuvia korvasylkirauhastulehduk-
sia hoidettaessa on muistettava myös pään ja kaulan alueen luutulehduksen mah-
dollisuus. Kaikkia korvasylkirauhastulehduksen aiheuttajia ei tunneta.
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1 INTRODUCTION
A colleague of mine suffered swollen cheeks and fever as a child eight times. Each 
time the doctor diagnosed mumps, and said, “Luckily you can only have this once.” 
Her mother replied, “Well thank you doctor, we hope it is true this time.” This was 
in the 60’s. Retrospectively, it easy to say that my colleague didn’t have mumps 
eight times. She had juvenile recurrent parotitis (JRP), which resolved by itself in 
puberty.
Redness, tenderness, and swelling of the parotid area, accompanied by elevated 
temperature, are the classical symptoms of parotitis. Chewing is painful, and opening 
of the mouth may be reduced. Before the vaccination era, parotitis in children was 
connected with paramyxovirus that caused mumps. However, since mumps has 
become rare in western countries – even eliminated in some places (Peltola et al., 
2000) – the etiology of existing parotitis remains in part unknown. In addition, 
the current epidemiology of parotitis is unknown.
The clinical picture of acute parotitis is in many cases suggestive of viral infection, 
and therefore it is assumed that other viruses cause infection and symptoms similar 
to mumps. At least parainfl uenza virus and adenovirus and – among herpesviruses 
– cytomegalovirus (CMV) and Epstein-Barr virus (EBV) (Davidkin et al., 2005), 
have been related to parotitis.
Bacterial infections of the parotid gland are, in most cases, secondary to some 
underlying condition such as reduced saliva fl ow, a salivary gland stone, dehydration, 
diabetes, or poor dental hygiene (Nusem-Horowitz et al., 1995). Viral parotid 
infection can predispose to bacterial invasion of the parotid gland as well. In some 
cases, bacterial infections can lead to more severe complications: local spread of 
infection, abscess formation, or generalized infection (Marioni et al., 2003). 
Some children suffer from juvenile recurrent parotitis  (JRP), which in some cases 
can be quite life-disruptive. JRP usually resolves in puberty (Galili and Marmary, 
1985, Geterud et al., 1988), but sometimes the symptoms persist into adulthood. 
Mostly one side is more affected, even though signs of infl ammation can often be 
visible on both sides in imaging. The pathogenesis of JRP is not fully understood. The 
role of microbes in recurrent symptoms is debatable, as well as need for antibiotic 
treatment (Isaacs, 2002, Vinagre et al., 2003). Different kinds of theories on the 
pathogenesis exist including autoimmune disease, local malformations, and genetics 
(Reid et al., 1998). 
Mandibular osteomyelitis, even more rare than JRP, can, however, have much 
the same symptoms. Intermittent swellings of the parotid area together with mild 
fever and pain can be suggestive of JRP as well as of osteomyelitis. Osteomyelitis, a 
more severe disease, requires quite different treatment: usually long antimicrobial 
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treatment and debridement, together with intensive follow-up (Dich et al., 1975, 
Syrogiannopoulos and Nelson, 1988 Prasad et al., 2007). 
In conclusion, the aim of the present study was to assess the clinical picture, 
epidemiology, etiology, differential diagnosis, and complications of juvenile parotitis 
currently.
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2 REVIEW OF THE LITERATURE
2.1 Parotid gland
The two parotid glands are situated in front of and below the ear, under the subcutis 
and mainly resting on the masseter muscle in close relation to the mandibular 
ramus (Figure 1). Parotid saliva is serose, and rich in amylase. It is present mainly 
when masticating, and food-odors launch the parotid salivation (Holsinger and 
Bui, 2007).
Two other sets of great salivary glands exist, in addition to the parotid glands: 
the submandibular and sublingual glands. Saliva secreted by these glands is more 
mucous in nature. Moreover, hundreds of little salivary glands are located under 
the mucosa of the mouth (Holsinger and Bui, 2007).
Figure 1. Child’s left parotid gland situated in front of the ear and over the mandibular ramus. The parotid 
(Stensen’s) duct runs parallel to the zygomatic bone and opens into the mouth at the level of the second 
upper molar. Artist: Seppo Piirainen.
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2.1.1 Embryology
Development of the parotid glands begins from the oral ectodermal out-pouchings 
extending into the adjacent mesoderm during the sixth to eighth embryonic weeks 
(Holsinger and Bui, 2007). At fi rst the branched duct buds start emerging, due to 
repeated epithelial bud and cleft formation. The early lobules and duct canalization 
appear during the second developmental stage, and in the third stage, the acini and 
intercalated ducts mature, whereupon the interstitial connective tissue diminishes 
(Gibson, 1983). A capsule forms from the ambient mesenchyme to surround the 
gland. The development and strengthening of the capsule continues in childhood. 
Development of the salivary glands is an example of branching morphogenesis, 
in which multicellular organs develop a complex morphology and a treelike 
arrangement through repetitive, self-similar branching (Jaskoll and Melnick, 1999, 
Holsinger and Bui, 2007).
2.1.2 Anatomy
The parotids are the largest of the salivary glands and weigh, on average, 15 to 30 g. 
The facial nerve emerges from the stylomastoid foramen and travels through the 
gland, branching into fi ve nerves within the gland, dividing the gland into superfi cial 
and deep lobes (Figure 2). Diseases of the parotid gland may affect the facial nerve, 
causing partial or total paresis (Andrews et al., 1989). Facial paresis related to a 
parotid illness is, however, often a sign of a severe condition. The deep lobe of the 
parotid gland projects into the parapharyngeal space. A capsule originating from 
the deep cervical fascia encloses the gland. An anterior accessory parotid gland is 
sometimes present (Holsinger and Bui, 2007).
The glossopharyngeal nerve – ninth cranial nerve – provides parasympathetic 
secretory innervation to the parotid gland via the tympanic nerve (Jacobsen’s nerve). 
The tympanic nerve – a branch of the glossopharyngeal nerve – synapses in the 
otic ganglion with fi bers from the trigeminal nerve to form the auriculotemporial 
nerve, which innervates the parotid gland (Figure 2). In addition, some secretory 
innervation to the parotid gland is provided from the facial nerve via the chorda 
tympani nerve. Branches of the external carotid artery supply blood, and venous 
drainage is through the retromandibular vein (Figure 2). It is important to notice 
that, contrary to other salivary glands, a high density of lymph nodes exists within 
and around the parotid gland (Holsinger and Bui, 2007), and as such they are not 
suggestive of any pathology.
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Figure 2. The facial nerve runs through the parotid gland. The blood supply is from branches of the 
external carotid artery, and venous drainage is through the retromandibular vein. Copyrght © O’Rahilly 
2009, reprinted with permission. 
Saliva from the parotid gland is secreted via the parotid duct (Stensen’s duct) into 
to the mouth through an orifi ce situated approximately at the level of the second 
upper molar (Figure 3). The parotid duct travels parallel to the zygoma across the 
masseter muscle, and pierces at a sharp angle the buccinator muscle when entering 
the mouth. The mean diameter of the parotid duct at different points ranges between 
0.5 mm and 1.4 mm, with a narrowing at the middle of the duct – the minimum 
width being, however, at the ostium (Zenk et al., 1998). 
Figure 3. Papilla (arrow) of the parotid duct on the buccal mucosa at the level of the second upper molar. 
Photograph: Riitta Saarinen.
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The basic unit of the salivary gland consists of an acinus, a secretory duct, and a 
collecting duct. A layer of myoepithelial cells, believed to have contractile properties 
and to play a role in expelling preformed secretions, surrounds each acinus. Acini 
are classifi ed as serous, mucous, or mixed. Parotid glands contain mainly serous 
acini (Elluru and Kumar, 2005).
2.1.3 Physiology
Saliva plays many roles, such as lubrication of foods, and digestive and antibacterial 
functions. Saliva is also extremely important in maintenance of tooth integrity. The 
parotid glands secrete approximately one quarter of the total amount of saliva, but 
during stimulation, the role of the parotid glands enlarges, and they are responsible 
for one-third of all salivation. The amount of various ions in saliva varies according 
to the secretion rate, but K+ concentration is always higher and Na+ lower than in 
plasma. The primary secretion produced by the acini is relatively isotonic to plasma, 
but as the saliva fl ows through the ducts, Na+ and Cl– are reabsorbed, whereas 
K+ and HCO3
- are secreted into the fl uid. Thus, with higher secretion rates, saliva 
concentration is more isotonic (Holsinger and Bui, 2007). In addition to electrolytes, 
saliva contains a complex mixture of macromolecules such as amylase, mucin 1 
and 2, lysozymes, lipase, glycoproteins, trypsin, and lactoferrin (Elluru and Kumar, 
2005, Holsinger and Bui, 2007).
2.2 Microbes in acute juvenile parotitis
Except for the mumps virus, the other causative agents of parotitis are not fully 
understood. Other viruses in addition to paramyxovirus have been related to 
mumps-like symptoms (Davidkin et al., 2005). Various secondary causes such as 
salivary stones, diabetes mellitus, or poor general condition predispose to bacterial 
parotitis (Nusem-Horowitz et al., 1995).
2.2.1 Mumps
Mumps or epidemic parotitis was the main cause of parotid infl ammation until 
the 1990s in Western countries, and this still is the case in many undeveloped 
countries. Mumps is an acute, self-limited viral infection occurring most often in 
school-aged children and adolescents; it is a member of the paramyxovirus genus. 
Parainfl uenza virus is another known member of the same genus. The mumps virus 
genome is composed of single-stranded RNA. Fomities and respiratory droplets 
transmit this virus (Pomeroy et al., 2008) for which the only natural hosts are 
humans (Bagg, 1996).
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Parotid infl ammation occurs in 60 to 70% of mumps infections, and in 95% 
of patients with symptoms. Parotitis is usually bilateral but can occur on one side 
only. Other symptoms of mumps are fever, headache, rash, pancreatitis, and 
orchitis. Symptoms are generally not severe in children. Males past puberty who 
develop mumps have about a 40% risk of orchitis, which may result in infertility or 
subfertility (Philip et al., 2006). Mumps is usually self-limiting, running its course 
before receding, with no specifi c treatment apart from controlling the symptoms 
with pain medication (Marchal and Bradley, 2007). Its incubation time is 14 to 21 
days, with its most contagious period being a few days before symptoms appear.
Vaccination against mumps was introduced to the Finnish national vaccination 
protocol in 1982 (Measles, Mumps and Rubella vaccine, MMR vaccine), and the 
last outbreak of mumps in Finland was in 1987 (Peltola et al., 1994, 2008). The last 
indigenous transmission was diagnosed in 1996 (Peltola et al., 2000). However, 
what must be kept in mind is that endemic mumps still exists in Third World 
countries, and despite comprehensive vaccinations, recent mumps outbreaks have 
occurred in Western countries as well. Small outbreaks have occurred at least in 
North America, the United Kingdom, and Spain during the last decade (Donaghy et 
al., 2006, Kancherla and Hanson, 2006, Peltola et al., 2007, Barskey et al., 2009). 
Differing mumps vaccine strains vary in effi ciency, and multiple dosing, which has 
been shown to be benefi cial, has not been used everywhere. Waning immunity may 
also play a role in the mumps outbreaks (Peltola et al., 2007). Therefore, it is still 
important to ask the travel and vaccination history of any child with parotitis. 
2.2.2 Viral parotitis other than mumps
Since children vaccinated against mumps still can experience mumps-like 
symptoms, we are justifi ed in speculating that other viruses cause these infections. 
Adenovirus, enterovirus, EBV, human herpesvirus 6 (HHV-6), parainfl uenza virus, 
and parvovirus have all been related to parotitis (Martinón-Torres et al., 1999, Akin 
et al., 2002, Davidkin et al., 2005). Davidkin et al. (2005) were able to show viral 
etiology in 84 (14%) of their 601 patients with mumps-like symptoms collected 
prospectively. Most commonly, they found EBV (7%), parainfl uenza type 2 or 3 
(4%), adenovirus (3%), and HHV-6 (4%, tested from children < 4 years). Akin et al. 
(2002) and Martinón-Torres et al., (1999), have each reported a case of complicated 
parvovirus-induced parotitis. Usually parvovirus infections are benign and self-
limiting, with typical appearance of erythema infectiosum.
Human herpesviruses (HHVs) – herpes simplex virus type 1 (HSV-1), varizella-
zoster virus (VZV), CMV, EBV, HHV-6 and human herpesvirus 7 (HHV-7), - are 
known pathogens of the respiratory tract (Zerr et al., 2005, Liljeqvist et al., 2009) 
with high saliva concentrations during acute infection. However, HHVs have also 
been detected in saliva of those who are asymptomatic. Speculation as to their role 
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in upper respiratory tract infections is therefore of special interest. Even though 
EBV and HHV-6 have been related to parotitis (Davidkin et al., 2005), the true 
role of herpesviruses in pediatric parotitis is unclear. 
HHV-6s are frequent fi ndings in child and adult saliva, HHV-6B being the variant 
most often encountered (Caserta et al., 2004, Pereira et al., 2004, Zerr et al., 2005). 
Its transmission is speculated to occur via saliva as well (Rhoads et al., 2007). Zerr 
et al. (2005) showed that HHV-6 infects the majority of children by the age of two. 
They concluded that most children are symptomatic during the primary infection, 
and the HHV-6 levels in saliva remain high at least for 12 months thereafter. The 
role of human HHV-7, a genetic relative of HHV-6, is more controversial (Caserta 
et al., 2004).
EBV causes infectious mononucleosis and is associated with many other 
respiratory tract pathologies: mucosal lesions, lymphoid and epithelial malignancies, 
and periodontitis (Slots et al., 2006). EBV resides in B-lymphocytes, and the salivary 
glands are considered a site of EBV production in the oropharynx (Morgan et al., 
1979). Akaboshi et al. (1983) have suggested that EBV might be of importance in 
the pathogenesis of JRP. Over 80% of the population in developed countries is 
infected with EBV before adulthood.
HSV-1 is present in the saliva of asymptomatic children and adults as a result of 
occasional viral reactivation (Spicher et al., 2001, Liljeqvist et al., 2009), whereas 
herpes simplex virus 2 (HSV-2) is not a respiratory tract pathogen. The occurrence 
of CMV and of VZV in saliva is less studied. Todoroki et al. (2006) associated a 
case of neonatal suppurative parotitis with congenital CMV infection. It has to also 
be kept in mind that new viruses are constantly found, and viruses play multiple 
roles in various diseases; it is therefore possible that more will be discovered about 
viral involvement in future.
2.2.3 Parotitis associated with human immunodeﬁ ciency virus (HIV) infection
Parotid gland enlargement occurs in up to 10% of HIV-positive patients (Soberman 
et al., 1991, Mandel and Witek, 2001, Gaitan-Cepeda et al., 2002). In children, other 
salivary glands are often involved as well, causing xerostomia, which affects the 
homeostasis of the mouth (Pinto and De Rossi, 2004). Dave et al. (2007) suggest 
that parotid lesions in HIV-positive patients can be divided into three categories: 
persistent generalized lymphadenopathy, benign lymphoepithelial cysts, and benign 
lymphoepithelial lesions. In most cases, parotid swelling is secondary to multiple 
lymphoepithelial cyst formation, which is otherwise rare (Shaha et al., 1993). Cystic 
parotid enlargement is therefore suggestive of HIV infection, especially in children 
(Dave et al., 2007). Lymphoepithelial lesions pose a bigger risk of transforming into 
lymphoma (Sato et al., 2002) than do other types of lesions. Parotid enlargement 
in HIV can also be diffuse in nature, as in juvenile recurrent parotitis.
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2.2.4 Bacteria
Bacterial infections of the parotid gland are more common in adults than in children 
(Laskawi et al., 2006), in many cases being related to some underlying condition like 
weak general condition, diabetes mellitus, or poor dental hygiene (Nusem-Horowitz 
et al., 1995, Stong et al., 2005). Obstruction to salivary fl ow also disposes to bacterial 
involvement. Pus may be discharged from the parotid duct. The bacteria encountered 
are typical of oral fl ora, and mixed infections are common. Staphylococcus aureus, 
Streptococcus pneumonia, and Haemophilus infl uenzae have been among the most 
common pathogens in suppurative parotitis (Giglio et al., 1997, Stoesser et al., 2012), 
together with anaerobic bacteria in adults (Brook, 2003).
Mycobacterium tuberculosis causes parotid infections on rare occasions, and 
usually the symptoms of the parotid region are accompanied by systemic symptoms 
such as cough, malaise, and fever (Chatterjee et al., 2001, Suleiman, 2001). Another 
rare cause of parotitis is meliodosis, endemic in parts of Southeast Asia, caused by 
Burkholderia pseudomallei found in soil and water (Lumbiganon et al., 2011). In a 
recent paper from Cambodia, Stoesser et al. (2012) found 74% of their 39 pediatric 
parotitis patient’s cultures positive for Burkholderia pseudomallei emphasizing 
the importance of this pathogen on certain areas. How et al., (2005) reported an 
incidence of 0.68 / 100,000 of pediatric meloidosis in Malyasia with 15% of the 
affected children presenting with parotitis as their fi rst symptom. 
Neonatal suppurative parotitis is an uncommon condition most often associating 
with Staphylococcus aureus, although case-reports also describe Staphylococcus 
epidermis (Chevalier and Jadcherla, 2002), Streptococcus pyogenec (Herrera-
Guerra and Osguthorpe, 2010) and anaerobic bacteria (Brook, 2001) induced 
suppurative neonatal parotitis. Only some 40 reports of this rare entity appeared 
in the English literature over recent decades (Spiegel et al., 2004). Neonates with 
acute suppurative parotitis require hospitalization and intensive follow-up, together 
with intravenous antibiotic therapy. Prematurity, dehydration, and male gender 
are considered the main risk factors (Spiegel et al., 2004, Özdemir et al., 2011, 
Decembrino et al., 2012).
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Table 1. Studies describing clinical features and outcome of juvenile parotitis and juvenile recurrent parotitis.
Reference
Number of 
patients  
Gender
Age, mean 
(range)
m = months
y = years
Aim of the study Conclusions
Follow-up, 
mean
(range)
m=months 
y=years
Geterud et al. 
1988.
Ann. Otol. Rhinol. 
Laryngol.
25
Boys, 18
6.5 y
(2.5–16 y)
To evaluate long-
term outcome of 
JRP.
In most patients, 
symptoms disappear by 
age 22 independent of 
treatment given.
(3 y or more)
Zou et al.1990.
Chin. Med. J.
102
Boys, 58
5.4 y
(2.5–14 y)
To evaluate clinical 
picture, and 
outcome of JRP.
URIs may dispose to 
JRP. Many patients have 
long symptom-free 
periods.
7 y
(1–23y)
Ericson et al. 1991.
Ann. Otol. Rhinol. 
Laryngol.
20
Boys, 12
7.2 y
(3 m–16 y)
To evaluate clinical 
picture, and 
outcome of JRP.
Congenital malformations 
and oral infections 
contribute to JRP. URIs 
and autoimmune causes 
play no role in JRP.
(7–22 y)
Leerdam et al. 
2005.
J. Paediatric. 
Child. Halth
53
Boys, 37
8 y
(1.5–16 y)
To evaluate clinical 
presentation, 
diagnosis, and 
management of 
JRP. 
JRP has a biphasic 
age distribution, male 
predominance; antibiotics 
play no role in treatment; 
Sjögren’s syndrome and 
immune deﬁ ciency should 
be screened.
Retrospective
Sitheeque et al. 
2006 Int. J. 
Paediatr. Dent.
26
Boys, 15
8.4 y
(2.5–16 y)
To evaluate clinical 
presentation, and 
sialographic, and 
ultrasonographic 
features of JRP.
JRP has a slight male 
predominance; sialography 
and ultrasound are useful 
tools in diagnosis.
–
Stong et al. 2006.
Int. J. Pediatr. 
Otorhinolaryngol.
21
Boys, 8
6.5 y
(6 m–15 y)
To evaluate clinical 
picture and 
management of 
parotis in children.
Pediatric parotitis is rare, 
admission should be 
reserved for those with a 
co-morbidity, leucocytosis, 
or fever; imaging is 
unnecessary unless, 
suspicion of abscess. 
5 y
JRP = Juvenile recurrent parotitis. URI = Upper respiratory infection.
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2.3 Juvenile recurrent parotitis
Juvenile recurrent parotitis (JRP) is an infrequent condition of unknown etiology 
(Baurmash, 2004). The peak onset of symptoms is at around four to six years, 
and the symptoms usually resolve after puberty (Ericson et al., 1991, Miziara and 
Campelo, 2005). Leerdam et al. (2005) showed a biphasic age distribution at two 
to fi ve years and at ten years (Table 1). It has been speculated that development 
of the immune system and growth of the parotid capsule contribute to the JRP 
resolution (Zou et al., 1990). However, in some cases the symptoms persist into 
adulthood (Chitre and Premchandra, 1997, Baurmash, 2004). Recurrent episodes of 
parotid swelling and pain can be life-disruptive, even though the overall condition 
of the patient remains good (Figure 4). In most cases, only one side is affected, but 
the symptoms may be bilateral (Shacham et al., 2009). Male dominance has been 
reported (Arrieta and McCaffrey, 2005, Leerdam et al., 2005). The main criterion 
for establishing the JRP severity is frequency of recurrence. 
Figure 4. A 3-year-old girl presenting with acute symptoms of right-sided recurrent juvenile parotitis: right 
parotid enlargement, pain and mild fever. Photograph: Riitta Saarinen.
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2.3.1 Etiology
Among theories on etiology, none has proven to be solid. Etiology may, in fact, be 
multifactorial. It has been suggested that allergy, congenital parotid malformations, 
infections, and genetic inheritance dispose to JRP (Giglio et al., 1997, Reid et al., 
1998, Wittekindt et al., 2000, Vinagre et al., 2003, Fazekas et al., 2005, Leerdam 
et al., 2005). Some suggest that JRP is a local manifestation, or early presentation 
of autoimmune diseases (Friis et al., 1983). JRP has been related to common 
variable immune defi ciency (Nguyen and Green, 2009), to IgG3 subclass defi ciency 
(Marsman and Sukhai, 1999), and considered a precursor of Sjögren’s syndrome 
(Flaitz, 2001, Munro and Allen, 2003, Houghton et al., 2005, Baszis et al., 2012).
Hara et al. (1992) diagnosed Sjögren’s syndrome in three (5,1%) of their 59 
recurrent parotitis patients but found autoantibodies transiently present in 12 (20%), 
and therefore recommended screening for underlying systemic immune disorders 
for children with late onset of JRP. Fazekas et al. (2005) showed selective IgA 
defi ciency in 22% of their 23 JRP patients, different from the cumulative prevalence 
of IgA defi ciency in healthy population of 0.3% (P < 0.001). Shkalim et al. (2004) 
have reported a JRP patient with selective IgA defi ciency without any accompanying 
autoimmune disease as well. Frati et al. (2011) recently reported a case of eosinophilic 
parotitis and recommended cytological assessment when patients with parotitis of 
uncertain origin are evaluated. 
From the clinical point of view, in the acute phase of JRP, the saliva is often milky 
and viscous with semisolid material, and molecular alternations in parotid saliva of 
JRP patients have been reported (Ericson and Sjoback, 1996a). Saliva analyses show 
an increase in albumin, lactoferrin, and kallikrein concentrations (Tabak et al., 1978, 
Ericson and Sjöback, 1996b,). Recently, Morales-Bozo et al. (2007) demonstrated 
higher overall protein concentration, increased matrix metalloproteinases 2 and 
9 (MMP-2 and MMP-9) concentrations, altered mode of protein diffusion, and 
higher frequency of some polypeptide bands in JRP, speculating that parotid saliva 
analysis could lead us to the foundation of the disease. Even more recently, they 
concluded that the levels of MMP-2 and MMP-9 could be useful in evaluating the 
degree of glandular damage and the effi ciency of medical trials (Morales-Bozo et 
al., 2008).
Even though Akaboshi et al. (1983) found some evidence of possible EBV 
involvement in JRP, and Giglio et al. (1997) have cultured Streptococcus pneumoniae 
and Haemophilus infl uenzae in their JRP patients, others have concluded that most 
likely there exists no microbial etiology behind recurrent symptoms, and therefore 
the treatment can be symptomatic (Isaacs, 2002, Vinagre et al., 2003, Leerdam 
et al., 2005). Vinagre et al. (2003) tested JRP patients for adenovirus, respiratory 
syncytial virus, parainfl uenza virus, infl uenza virus, CMV, HSV, EBV, and mumps. 
Because viral infections were detectible in only seven (14%) among 50 cases, they 
concluded that the main respiratory and oropharyngeal viruses are not the cause 
of acute episodes of JRP (Table 2). 
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Reference
Number 
of 
patients / 
controls
Age years 
(Range)
Gender
Acute / 
Recurrent
Parotitis
Pathogens 
studied
Pathogens found
Study group / controls Conclusions
Akaboshi
et al. 1983 34 / 40
–
(2.0–12)
Boys, 19
Recurrent *EBV
*EBV antibodies 
suggestive of a 
persistent carrier in 29 
cases (85%) /
None had EBV 
antibodies suggestive of 
a persistent carrier
*EBV may 
associate with JRP
Giglio
et al. 1997 56 / 20
6.1
(2.0–11)
Boys, 36
Recurrent Bacteria
91% positive: S. 
pneumoniae, H. 
inﬂ uenzae, Moraxella 
catarrhalis, Viridans 
streptococcus /
65% positive: Moraxella 
catarrhalis, Viridans 
streptococcus
S. pneumoniae, 
and H. inﬂ uenzae 
associate with JRP
Nusem-
Horowitz
et al. 1995
20
4.4
(9d–14y)
Boys, 13
Acute Bacteria
10 cases of suppurative 
parotitis, of which 40% 
positive: Bacteroides 
fragilis, Staphylococcus 
aureus, Klebsiella species
– 
Vinagre
et al. 
2003
70 / 20
5.6
(1.0–12)
Boys, 29
Recurrent
*Adenovirus, 
enterovirus, 
RSV, 
parainﬂ uenza 
virus, 
inﬂ uenza 
virus, CMV, 
HSV, mumps
*14% positive: CMV, 
enterovirus, inﬂ uenza 
virus A, mumps /
10% positive: mumps
Viruses do not 
associate with JRP
**Davidkin
et al. 
2005
601
–
(1.6–19)
Boys, 373
Acute
*EBV, 
adenovirus, 
enterovirus, 
parainﬂ uenza 
virus, 
parvovirus, 
HHV-6
*14% positive: EBV, 
adenovirus, enterovirus, 
parainﬂ uenza virus, 
parvovirus, HHV-6
Various viruses 
may cause 
mumps-like 
symptoms
*RSV = respiratory syncytial virus, CMV = cytomegalovirus, HSV = herpes simplex virus, EBV = Epstein-Barr 
virus, HHV-6 = human herpesvirus 6.
**Acute mumps was excluded in an earlier phase of the study.
Table 2. Pathogens in acute parotitis and juvenile recurrent parotitis reported in the literature.
The development of miniature endoscopes has made intra-ductal investigation 
of the salivary glands possible. The main fi ndings in endoscopic investigation are 
in the parotid duct: dilatations and strictures, a whitish appearance of the ductal 
layer, and lack of normal blood vessels (Nahlieli et al., 2004, Shacham et al., 2011). 
Fibrotic plaques are often visible. Like other imaging methods, endoscopy of the non-
symptomatic side, often reveals signs of infl ammation, as well. Studies on glandular 
tissue from patients with JRP have shown lymphocytic infi ltrates and lymphoid 
follicles around dilated interlobular ducts (Ussmuller and Donath, 1999).
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2.3.2 Genetics
Reid et al. (1998) have described a family with four members affected with JRP, 
and others have also reported families in which two siblings or members of more 
than one generation were affected leading to speculation about possible genetic 
inheritance as a predisposing factor for JRP (Galili and Marmary, 1985, Sitheeque 
et al., 2007). 
Recently, what has been recognized is that children and adolescents with chronic 
pancreatitis have a high (23%) incidence of mutations in the serine protease inhibitor 
Kazal-type 1 (SPINK-1) (Pfützer et al., 2000, Witt et al., 2000 Chen et al., 2001, 
Drenth et al., 2002). SPINK-1 has functional importance in the pancreas as it inhibits 
proteolytic trypsin activity and tissue destruction. Pfützer et al. (2000) concluded 
that SPINK-1 mutations act as disease modifi ers, altering the phenotypic expression 
of pancreatitis. N34S and P55S SPINK-1 mutations are, however, mostly found 
in patients with idiopathic pancreatitis without any family history of the disease 
(Witt et al., 2000). According to a study by Lempinen et al. (2005) prevalence of 
the N34S mutation of SPINK-1 is 2.6% and of the P55S mutation 1.3% among the 
Finnish blood donors, which is more frequent than reported elsewhere. The pancreas 
and salivary glands have similarities in function, making it therefore tempting to 
speculate that chronic juvenile parotitis and recurrent pancreatitis might share 
genetic similarities as well. 
2.4 Radiological imaging of the parotid gland
Ultrasound (US) is a readily available, non-invasive, and reliable tool for salivary 
gland imaging (Sitheeque et al., 2007, Sodhi et al., 2011). It is useful as the initial 
diagnostic method for various pathologies of the neck. It visualizes lymph nodes, 
salivary glands, and the thyroid as well as other soft tissue structures well. In addition, 
US can aid in surgical procedures such as abscess incision (Gritzmann et al., 2003) 
or needle aspiration. With  US, the fi ndings suggestive of parotitis are multiple hypo-
echoic areas, heterogeneous echogenicity, and in many cases, sialectasis (Sitheeque 
et al., 2007). In their review article Sodhi et al. (2011) conclude that high resolution 
US remains the fi rst-line imaging modality for evaluation of the parotid gland in 
pediatric patients.
If further diagnostics is needed, magnetic resonance imaging (MRI) is the best 
choice in children, since computer tomography (CT) exposes patients to radiation. 
In addition, MRI is superior to CT in demonstrating soft-tissue changes (Reinert et 
al., 1999). MRI sialography is a new method in salivary diagnostics, enabling a three-
dimensional view of the salivary ductal system without contrast media (Wittekindt 
et al., 2000, Gadodia et al., 2011). MRI sialography is non-invasive, and possible 
to use during acute infection as well, but unfortunately the availability of MRI 
sialography is limited. 
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Sialography with intra glandular contrast media has been the standard in salivary 
gland imaging, but nowadays non-invasive methods have replaced it (Rubaltelli 
et al., 1987, Encina et al., 1996, Shimizu et al., 1998). In addition Shimizu et al. 
(1998) concluded that US is more sensitive than sialography in both primary and 
recurrent parotitis. Findings most suggestive of parotitis in sialography are multiple 
sialectasias. In addition, sialendoscopy can serve as a diagnostic tool as well as a 
treatment modality (Capaccio et al., 2008).
2.5 Management of parotitis
Treatment modalities for acute parotitis include symptomatic treatment with non-
steroidal anti-infl ammatory drugs (NSAIDs), milking of the gland, sialogogues 
(Isaacs, 2002, Fazekas et al., 2005), and antibiotics. However, stimulating 
salivary fl ow by milking in the acute phase may be impossible due to pain, and 
the role of antibiotics is controversial. It is possible that a signifi cant proportion 
of primary parotid infections are of viral origin (Davidkin et al., 2005). In JRP, 
the microbe etiology behind the recurrent symptoms is even more controversial, 
and some researchers favor symptomatic treatment (Isaacs, 2002, Vinagre et al., 
2003, Leerdam et al., 2005). However, antibiotics for the acute phase of JRP are 
still often the choice (Arrieta and McCaffrey, 2005, Sitheeque et al., 2007), even 
with no clear evidence of their benefi ts (Isaacs, 2002), since it is speculated that 
reduced glandular function with reduced salivary fl ow predisposes the gland to oral 
pathogens emerging via the parotid duct. 
Treatment of JRP consists of relieving the acute symptoms and preventing 
reoccurrences. Bowling et al. (1994) did a double-blind study on rabbits to 
demonstrate acinar atrophy after intra-glandular tetracycline therapy, concluding 
that tetracycline would be effective in JRP-symptom reduction. Even oral-appliance 
positioning has been tried to treat JRP, since one of the hypothesis is that dental 
malocclusion with mandibular misplacement may be a causative agent through 
unbalanced masticatory muscles (Bernkopf et al., 2008). Nowadays, watchful 
waiting has become a common practice in JRP, because the condition is known 
often to resolve in puberty (Geterud et al., 1988, Ericson et al., 1991, Isaacs, 2002). 
In addition to this spontaneous recovery in puberty, JRP has also been shown to 
improve with time (Zou et al., 1990, Miziara and Campelo, 2005,). It has also been 
speculated that treatment type has no impact on long-term outcome (Geterud et 
al., 1988).
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2.5.1 Sialendoscopy and intra glandular lavage
In 1986 Galili and Marmary showed that patients with JRP who underwent 
sialography had, at least to some extent, relief of their symptoms. Most likely the 
symptoms decreased due to enlargement of the ductal system and lavage of the 
debridement. Thereafter, various substances such as saline, methyl violet, and 
cortisone have been applied to lavage parotid glands of JRP patients (Wang et al., 
1998, Nahlieli et al., 2004) (Table 3). Intra-ductal treatment of chronic sialadenitis 
with penicillin and saline has been tried in adolescents and adults with promising 
preliminary results (Antoniades et al., 2004). Recently Katz et al. (2009) have 
treated their pediatric parotitis patients with iodine sialography and report no 
recurrences of symptoms in children treated after the fi rst episode, and an average 
one-year symptom-free interval in patients treated after two or multiple episodes. 
They conclude that the antiseptic infl uence of iodine was capable of reducing their 
patient’s’ symptoms for as many as 98%. However, they report no control group, 
but compare their fi ndings to the frequency of symptoms before their treatment. 
Reference
Number of 
patients
Gender
Age, 
mean 
(range)
years
Treatment
modality
Given 
treatment Outcome
Follow-up, 
mean
(range)
m=months 
y=years
*Galili and 
Marmary 1986
22
Boys, 14
4.0
(0.5–8.0 Sialography
Contrast 
medium
Decreased 
symptoms in 
86%
–
*Wang et al.
 1998
16
Boys, 10
–
(16–58) Canalization
Methyl violet 
1%
2 relapses
No relapse 
after 2nd 
treatment
–
(0.5–7.0 y)
Nahlieli et al. 
2004
26
Boys ,14
7.0
(2.5–13) Sialendoscopy
Saline and 
100 mg 
hydrocortisone
No relapse –(4.0–36 m)
Antoniades et 
al., 2004
27
Boys, 16
–
(8.0–65) Canalization 
Penicillin, 
saline, or both
2 relapses
No relapse 
after 2nd 
treatment
–
(1.0–14 y)
Quenin et al. 
2008 10
–
(1.8–13) Sialendoscopy Saline One relapse 
11 m
(2.0–24 m)
Katz et al. 
2009
840
Boys, 437
4.5
(0.5–14) Canalization Iodinated oil
12 symptom-
free months 
on average
(range 6–18)
5.5 y
(2.0–9 y)
Shacham et al.
2009
70
Boys, 43
–
(1.0–14) Sialendoscopy
Saline and 
100 mg 
hydrocortisone
13 relapses 
+ 1 recurrent 
relapse
12 m
(6.0–36 m)
No study had a control group.
*Intention of treatment was to introduce gland atrophy.
Table 3. Representative studies of treatment of juvenile recurrent parotitis.
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2.5.2 Surgical treatment
Tympanic neurectomy has been a method for treating chronic parotitis (Benedek-
Spat and Szekely, 1985, Vasama, 2000). Part of the nerve lying across the cochlear 
promontory is removed via a tympanic approach. Most of the neural innervation of 
the parotid gland occurs via the tympanic nerve (Jacobson’s nerve), and therefore 
cutting off its fi bers diminishes glandular activity and leads to atrophy. But since 
JRP is usually self-limiting in puberty, a wait-and-see policy has replaced tympanic 
neurectomy in young patients. In addition, because some nerve fi bers travel to the 
parotid gland via the corda tympani nerve, then cutting solely the tympanic nerve 
does not always result in the desired outcome. Concurrent cutting of the corda 
tympani improves the results but may affect permanently the sensation of taste.
Ductal ligation has been used to initiate glandular atrophy, as well (Chitre and 
Premchandra, 1997, Baurmash, 2004), and parotidectomy for treatment of frequent 
JRP has also been described (Moody et al., 2000, Orvidas et al., 2000, Laskawi 
Development of miniature endoscopes has made it possible to visualize the inside-
gland appearance of juvenile parotitis in addition to intra-glandular treatment (Figures 
5a, 5b, and 5c). Recently, sialendoscopy has become a common preventive treatment 
modality (Nahlieli et al., 2004, Quennin et al., 2008). Sialendoscopy is minimally 
invasive: an endoscope with a diameter from 0.8 to 1.1 mm is introduced into the parotid 
duct via the papilla. For most children, however, this procedure needs to be done under 
general anesthesia. Nahlieli et al (2004) were the fi rst to report endoscopic treatment 
of JRP patients. They treated 26 symptomatic JRP children with sialendoscopy, saline 
lavage, and 100 mg intra-ductal hydrocortisone administered through the endoscope 
under visual control with good results. All children were symptom-free during the 
4 to 36 months’ follow-up. However, two developed symptoms on the contralateral 
side. The pitfall of the study was the absence of a control group. Others have also 
reported good results from endoscopic treatment and ductal dilatation, although these 
studies lack a control group as well (Leerdam et al., 2005, Shacham et al., 2009, 
Martins-Carvalho et al., 2010). In any case, endoscopes have brought new aspects to 
the treatment and diagnosis of JRP. 
Figure 5. Sialendoscopy view of a normal parotid duct (a). In juvenile recurrent parotitis, avascular ductal 
wall (b and c) with typical ﬁ brin plaques (c). Photographs: Riitta Saarinen.
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et al., 2006). However, parotidectomy is quite a radical procedure, and should be 
reserved only for extremely severe and prolonged cases when other treatments 
provide no relief. Encounters with the facial nerve occur during surgical procedures 
in the parotid area.
2.6 Diff erential diagnosis and complications
Other diseases of the head and neck area may mimic symptoms of parotitis and 
must be taken into account. In addition, on rare occasions, infection of the parotid 
gland may lead to dangerous complications. 
2.6.1 Diff erential diagnosis
Lymphadenitis and cellulitis are common infections of the head and neck. Especially 
in children, lymphadenitis is often related to viral respiratory tract infections and 
tonsillitis. Unilateral lymphadenitis is often a sign of bacterial infection, so uncommon 
pathogens such as toxoplasmosis, cat-scratch disease, and atypical mycobacterial 
infection must be considered in addition to more frequent Streptococcus and 
Staphylococcus infections. Insect bites and allergic reactions may cause a similar 
redness and tenderness of the affected area, but these conditions lack other signs 
of infection.
2.6.1.1 Mandibular osteomyelitis
Mandibular osteomyelitis in children is rare. Pediatric osteomyelitis is most often 
of hematogenous origin, but can also result from local infection or trauma or be 
secondary to vascular insuffi ciency. In mandibular and maxillar osteomyelitis, a 
tooth follicule is the potential origin of the infection (Schuknecht et al., 1997, Prasad 
et al., 2007, Pigrau et al., 2009).
Osteomyelitis is classically divided into three forms: acute, subacute, and primary 
chronic. The chronic form differs from the others by its prolonged symptoms, 
ones lasting more than four weeks. At present, primary chronic osteomyelitis is 
considered a distinct disease, representing a chronic non-suppurative infl ammation 
(Baltensperger et al., 2004). It seems that the mandible in particular is susceptible to 
the chronic form of osteomyelitis (Prasad et al., 2007). Moreover, acute osteomyelitis 
may on some occasions become a chronic disease, and chronic osteomyelitis may 
result in variable sclerosis and deformity of the affected bone (Ducic, 2008). Often 
no microbes can be cultured from bone, and surgery is ineffective (Eyrich et al., 
2003). In addition, a chronic multifocal form of osteomyelitis occurs in children 
and adolescents, mainly affecting the metaphyses of the long bones; but other parts 
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of the skeleton, as well as other organs may be concomitantly affected (Otsuka et 
al., 1999, Girschick et al., 2007, Monsour and Dalton, 2010). 
In acute osteomyelitis, bacteria or other microorganisms are embedded in a 
suppurative infl ammation with various infl ammatory factors and leucocytes also 
present. Eventually the process leads to obliteration of the vascular canals and to 
tissue necrosis. Avascular segments of dead bone, sequestra, can continue to collect 
bacteria despite antibiotic treatment. Increased osteoclastic activity at the edge of the 
infl ammation produces bone loss and localized osteoporosis (Lew and Waldvogel, 
2004). The bacterium most often encountered in osteomyelitis is Staphylococcus 
aureus (Vinod et al., 2002). 
For suspected bone involvement in infection, panoramic radiography, CT, and 
MRI can serve as imaging modalities. Ultrasound is not suitable for bone imaging. CT 
can be considered the gold standard for imaging cortical bone defects and calcifying 
periosteal reactions and bone sequestra (Schuknecht et al., 1997). MRI can, to some 
extent, also evaluate bone structures (Lee et al., 2003). In a pediatric population, 
MRI is especially valuable because of its lack of ionizing radiation.
Osteomyelitis should be treated intensively, and usually long courses of 
antibiotics are needed. However, some evidence, especially in children, speaks for 
the effi ciency of shortened courses of antibiotics (Peltola et al., 1997, Vinod et al., 
2002, Malcius et al., 2005), but no clear consensus exists (Weichert et al., 2008). As 
adjuvant therapy, debridement of the infected area is often benefi cial, and sometimes 
more radical surgery is also necessary (Montonen et al., 1993, Eckardt et al., 1994). 
Despite intensive therapy, healing of osteomyelitis can be problematic. Adjuvant 
treatment options include hyperbaric oxygen (HBO) therapy (Aitasalo et al., 1998, 
Lentrodt et al., 2007). Recently, bisphosphonate treatment for chronic osteomyelitis 
has shown promising results in cases resistant to conventional therapy (Soubrier et 
el., 2001, Yamazaki et al., 2007, Gleeson et al., 2008, Simm et al., 2008).
2.6.1.2 Actinomycosis
Anaerobic, gram-positive Actinomyces causes granulomatous infection, which 
in many cases turns into a chronic disease. The infection travels through tissue 
borders, affecting soft tissue as well as bone (Bennhoff, 1984, Stewart et al., 2005). 
Its diagnosis is based on sulfur-granules seen in tissue samples. Actinomyces is 
part of the normal oral fl ora, and in the orofacial area, the origin of the infection is 
likely to be dental (Ohlms et al., 1993, Sharkawy, 2007). The symptoms are often 
fl uctuant and subtle: the overall condition of the patient remains good (Yenson et 
al., 1983, Robinson et al., 2005). 
In most cases, a permanent cure requires bone debridement and long 
antibacterial treatment, but there is no clear consensus as to the ideal therapy 
(Bartkowski et al., 1998, Robinson et al., 2005). Actinomyces species are usually 
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susceptible to penicillin, clindamycin, and tetracycline, all of which should penetrate 
well into bone (Smego and Foglia, 1998). Other organisms may complicate the 
infection. Bartowski et al. (1998) report a series of 15 patients with mandibular 
actinomycosis, of which three had a single reoccurrence; all were treated surgically, 
and the antibiotic treatment ranged from three weeks to one and half months. 
Robinson and colleagues reported in 2005 four juvenile cases of osteomyelitis of 
the mandible caused by Actinomyces, and recommended three-month antibiotic 
treatment, with repeated debridement in any case of relapse. According to others, 
even longer courses of antibiotics and a more radical surgical approach may be 
necessary (Friduss and Maceri, 1990, Ohlms et al., 1993).
2.6.1.3 Other causes of parotid swelling
Masseter hypertrophy, which results from constant clenching, bruxism, or gum 
chewing, can be mistaken for parotid enlargement (Mandel and Surattanont, 2002). 
A fi rst branchial cleft cyst is an infrequent malformation of the parotid area that can 
lead to recurrent swelling and infections. An infected branchial clef cyst may present 
as an abscess of the parotid gland. However, the symptoms usually re-emerge, and 
a cure can only result from surgery (Triglia et al., 1998, Daniel et al., 2003). 
Frequent vomiting in bulimia can cause parotid swelling, and in obese people 
the glands are often constantly swollen (Touyz et al., 1993, Bozzato et al., 2008). 
Pneumoparotitis resulting from air being forced through parotid duct also occurs in 
children, although rarely (Goguen et al., 1995). Parotid neoplasia is rare in children, 
but must be taken under consideration, if the swelling of the gland is constant or 
a lump appears. Pleomorphic adenoma is the most common benign lesion of the 
parotid gland in children, with malignancy also a possibility (Orvidas et al., 2000, 
Daniel et al., 2003). Bilateral recurrent parotitis can also be a single sign of pediatric 
Sjögren’s syndrome (Baszis et al., 2012) or sarcoidosis (Surattanont et al., 2002).
2.6.1.4 Complications
Bacterial parotitis is a potentially life-threatening disease, since the parapharyngeal 
space lies in close contact with the parotid gland, and the infl ammation can spread, 
causing fasciitis (Marioni et al., 2003), deeper head and neck abscesses (Cmejrek 
et al., 2002, Kishore et al., 2004), Lemiere’s syndrome, or mediastinitis. Parotitis 
may lead to facial nerve paresis (Andrews et al., 1989, Martinón-Torres et al., 1999, 
Stoesser et al., 2012).
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2.6.1.5 Parotid abscesses
One rare complication of acute suppurative parotitis is a parotid abscess. In adults 
it is often related to poor oral hygiene, long-term debility, and reduction in salivary 
fl ow (Brook, 2003). However, such an abscess can also appear in relatively young and 
fi t adults with no history of oral pathologies (Nusem-Horowitz et al., 1995, Ganesh 
and Leese, 2005,). In children, few reports exist of parotid abscesses. Ductal stones 
are rare in children, which supports the fi nding that parotid abscess formation is 
in most cases of non-obstructive origin (Ganesh and Leese, 2005).
The symptoms of a parotid abscess include marked swelling of the angle of the 
jaw, and pain while eating. Regional lymphadenitis may occur, as well as purulent 
secretion from the parotid duct. The treatment includes broad-spectrum intravenous 
antibiotics, good oral hygiene, and adequate hydration. If an abscess has formed, 
surgical drainage is advisable (Brook, 2003). 
Various bacteria are involved in the parotid infl ammation process: Staphylococcus 
aureus, Streptococcus pneumonia, Haemophilus infl uenza, and anaerobic bacteria. 
(Giglio et al., 1997, Brook, 2003, Ganesh and Leese, 2005,). One case-report even 
describes a candida parotid abscess (Even-Tov et al., 2006). Tuberculosis of the 
parotid gland is rare even where the disease is endemic; patients usually have long-
duration swelling of the parotid gland together with systemic symptoms such as 
cough, fever, and weight loss (Chatterjee et al., 2001, Suleiman, 2001). 
Surgical drainage is usually necessary in curative treatment of an abscess (Brook, 
2003), but the development of effi cient antimicrobial treatment has shifted the initial 
treatment towards more conservative direction. Surgical methods include quite 
radical procedures such as multiple drainage incisions or raising a full posterior-
based fl ap as in parotidectomy. But it seems that in most cases, a smaller procedure 
is suffi cient (Ganesh and Leese, 2005), especially when modern imaging techniques 
can assist in the procedure accompanied by broad-spectrum antibiotic therapy.
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3 AIMS OF THE STUDY
The purpose of this study was to understand the current clinical picture, epidemiology, 
etiology, differential diagnosis, and complications of pediatric parotitis.
Specifi c aims were:
1. To determine the clinical characteristics of juvenile parotitis in a 
prospective and a retrospective setup, and to map its epidemiology. 
2. To determine the possibility of SPINK-1 mutations as a factor 
predisposing to juvenile parotitis. 
3. To assess whether herpesviruses (HSV-1, HSV-2, VZV, EBV, CMV, 
HHV-6, or HHV-7) are etiological factors in pediatric parotitis. 
4. To assess the differential diagnosis between juvenile parotitis and 
mandibular osteomyelitis.
5. To asses the parotid abscess as a complication of parotitis.
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4 SUBJECTS AND METHODS
The study consists of fi ve studies, all conducted at Helsinki University Central 
Hospital, a tertiary care hospital covering about 1.4 million inhabitants, at the 
Department of Otorhinolaryngology - Head and Neck Surgery, and at Children’s 
Hospital. 
4.1 Patients and controls
Study I
All consecutive pediatric patients (n=44) with a primary diagnosis of acute parotitis 
admitted between 2005 and 2010 were recruited for this prospective study of juvenile 
parotitis. Three patients were excluded due to incorrect primary diagnoses (described 
in Study IV). A control group comprised 38 sex- and age-matched children.
The type and duration of symptoms were recorded together with clinical fi ndings, 
treatments given, history of previous episodes of parotitis, family history of parotitis, 
and imaging methods. Laboratory investigations included C-reactive protein (CRP), 
blood leukocyte count, serum amylase, and serum trypsinogen 2. SPINK-1 genotype 
was determined, and any purulent excretion from the parotid duct was sampled for 
bacterial culture. Mumps antibodies type IgG and IgM were determined from saliva 
of parotitis patients (n=22) and of 34 age- and sex-matched control children who 
came for an elective otorihinolaryngological surgery, were healthy at the moment 
and had no history of parotitis. To map the recurrence of parotitis, all children 
with a primary episode of parotitis at recruitment were telephoned a year after 
the study was closed. 
Study II
Clinical records of all children admitted to Helsinki University Central Hospital, 
Department of Otorhinolaryngology between 1995 and May 2003 due to swelling of 
the parotid gland were reviewed retrospectively, with 142 children and adolescents 
with parotid swelling successfully traced. Two children of non-Finnish origin were 
excluded due to inadequate communication, and seven children had parotid-
related symptoms instead of true parotitis. This produced a total of 133 children 
and adolescents. Treatment given, outcome, recurrences, blood leukocyte count, 
CRP, and imaging methods were recorded. A postal questionnaire covered possible 
recurrences, and familial cases of parotitis, or pancreatitis, and children were 
asked to give a blood sample for determination of mutations in the SPINK-1 gene. 
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4 Subjects and methods
Questionnaires fi lled in by guardians of 48 children admitted for elective surgery 
served as controls. Forty-seven patients agreed to SPINK-1 status testing. For the 
SPINK-1 study another control group of 39 children admitted to our clinic for elective 
surgery was collected. The results were contrasted, in addition to the control group, 
also to fi gures in a recent study by Lempinen et al. (2005) on the prevalence of 
N34S and P55S mutations among Finnish blood donors. 
Study III
Thirty-fi ve saliva samples, obtained in the acute phase, of children (boys 19) aged 17 
years or younger (median age 7.6, range 2.6-17) with acute parotitis were analyzed 
for HHVs (HSV-1, HSV-2, VZV, CMV, EBV, HHV-6 and HHV-7). From age- and 
sex-matched children who came for an elective otorhinolaryngological surgery, were 
healthy at the moment, and had no history of parotitis came 34 control samples. 
Another control group comprised ten healthy adult dental hygienists with excellent 
oral and dental status. 
Study IV
Three patients with osteomyelitis of the mandible, ones excluded from Study I, were 
included in this study together with three other children with osteomyelitis diagnosed 
and treated earlier. All these six children had initially been treated as JRP patients. 
Diagnostic codes according to the Classifi cation on Diseases, 10th revision (ICD-10), 
for parotid illnesses and osteomyelitis were included in the data base search of the 
Helsinki University Central Hospital Department of Otorhinolaryngology – Head 
and Neck Surgery to fi nd all pediatric patients with osteomyelitis treated between 
1998 and 2009. 
Study V
The diagnostic codes for parotid illnesses and for abscesses in the head and neck 
region were included in the data base search of the Helsinki University Central 
Hospital, Department of Otorhinolaryngology – Head and Neck Surgery, according 
to the ICD-10 involving all patients aged ≤17 treated between 1996 and 2005 at our 
institute. Review of the patient charts revealed ten children with parotid abscesses 
within this time period. Clinical data recorded included age, gender, site of the 
disease, laboratory results, imaging, drainage methods, length of hospitalization, 
bacteria, antibiotics used, and outcome, as well as other illnesses of importance 
such as parotitis, anomalies, and general health.
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4.2 Methods
4.2.1 Saliva sample
A 2-ml saliva sample stimulated by parafi lm chewing was attempted in the acute 
phase by all patients and control children participating in Study I, but due to reduced 
salivary fl ow in acute infection, and the lack of co-operation from some children,  the 
total number of saliva samples (0.1–2 ml ) was 35 in the parotitis and 34 in the control 
group. Analyses of HHVs were possible for all samples, and mumps antibodies of 
class IgM and IgG were possible for 22 parotis and 34 control samples.
4.2.2  Herpesvirus analyses
A total of 35 saliva samples from children with acute parotitis, 34 control samples 
from healthy controls, and ten adult control samples were analyzed with the Prove-
itTM Herpes TubeArray system and Prove-itTM Advisor software (Mobidiag Ltd, 
Finland) for HSV-1 and 2, VZV, CMV, EBV, and HHV-6 and -7. DNA extraction 
was with the automated extraction device EasyMAG and Generic 2.0.1 program 
according to manufacturer’s instructions (bioMérieux, France). After the polymerase 
chain reaction (PCR), the amplicons were subjected to hybridization onto TubeArray, 
following the Prove-itTM Herpes protocol 2.0 (Jääskelainen et al., 2008).
4.2.3 SPINK analysis
Blood samples were tested for mutations in the SPINK-1 gene encoding the Kazal-
type trypsin inhibitor. N34S and P55S mutations of SPINK-1 were analyzed as 
described by Lempinen et al. (2005).
4.2.4 Mumps antibodies
Mumps IgM and IgG antibodies in saliva were measured by the capture 
enzyme immunoassay (EIA) test (Microimune Ltd, England) according to 
manufacturer’s instructions (Warrener and Samuel, 2006). The cut-off optical 
density value of the antibody positivity was set for the negative controls (for IgM 
mean x 1.4 and for IgG mean x 2).
4.2.5 Epidemiologic survey
A questionnaire about general health, vaccination history, verifi ed diagnoses of 
parotitis, and possible parotitis-related symptoms and diagnoses of parotitis in 
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close family members was sent to 1,000 children aged 13 living in the district of 
Helsinki University Central Hospital. They were randomly drawn from the Finnish 
national population register. The age group of 13 years was chosen, since according 
to Study II, the fi rst episode of juvenile parotid symptoms occurs at a median age 
of six, but towards adulthood other causes, such as bacterial infection and ductal 
stones, start to predominate. If the fi rst invitation to the questionnaire survey had 
no response, the questionnaire was re-mailed. Children were asked to fi ll in the 
questionnaire together with their parents. 
4.2.6 Statistical analyses
The Mann-Whitney U-test and Spearman’s rank correlation test served for non-
parametric comparisons, and Fisher’s exact test for other comparisons. Differences 
were considered signifi cant at a p-value <0.05.
4.3 Ethics
The institutional ethics committee approved all study protocols. Guardians and 
the children, if old enough, signed a written informed consent. The studies were 
conducted according to the Declaration of Helsinki and good clinical practice.
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5 RESULTS
5.1 Clinical picture of juvenile parotitis (I, II)
The clinical prospective study on juvenile parotitis included 41 patients (26 boys) 
aged ≤17 years (median 6.2, range 2.0–17). All patients had acute symptoms 
of parotitis: swelling and pain in the parotid area. The mean duration of acute 
symptoms before the fi rst visit was 2.0 days (range 0.5–7.0) (Table 4). All children 
practiced good dental hygiene and had no concomitant illnesses. They all claimed 
to have been vaccinated according to the national vaccination protocol including 
the MMR vaccination. Analysis of IgM and IgG type antibodies showed no acute 
mumps. (Study I)
CRP was elevated in 28 (68%) patients (median 13 mg/l, range 5.0–170), but 
only 13 children had CRP values over 40; 11 patients (27%) had an elevated blood 
leukocyte count (median 11.5 E9/l, range 5.0–20.8). Serum amylase values were 
elevated in 30 of 38 (79%) cases (median 261 U/l, range 24–1220, not determined 
n=3) (Table 4a). Six children with normal serum amylase reported recurrent 
symptoms. None of the patients had elevated serum trypsinogen values. In 8 cases 
(20%) purulent secretion came from the parotid duc; bacterial culture showed 
Haemophilus infl uenzae in one case and normal oral fl ora in the rest. (Study I)
In 17 children (41%) temperatures exceeded 38°C. In 20 cases (49%), the 
diagnosis was based on clinical symptoms and elevated serum amylase value, and 
in 21 other cases the diagnosis was verifi ed by an US examination, which showed 
enlarged, hypoechoic parotid gland and reactive intra-glandular and regional lymph 
nodes in all parotitis patients. Some cases revealed signs of sailenctasia. All those 
children with a previous episode of parotitis had their diagnosis verifi ed by US. 
Of the 41, 34 children were treated as outpatients and 7 (17%) were hospitalized. 
All admitted patients received antibiotics, as did 13 outpatients. Intra-venous 
cefuroxime was the choice for admitted patients, and cephalexin for those treated 
as outpatients except in 2 cases with amoxicillin and clindamycin. Twenty-one 
children (51%) received symptomatically non-steroidal anti-infl ammatory drugs 
(NSAIDs) only (Table 4b). 
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Study II found 133 children and adolescents with parotitis (median age at admission 
8.0 years, range 1–19, 82 boys), 10% of whom had an associated ailment. Their fi rst 
episode of parotitis had occurred at a median age of 6.0 years. The diagnosis was 
confi rmed by US in 88% (97 of 110) of the children undergoing this examination, 
and bilateral changes in US appeared in 17% (12 of 71) of the 71 cases presenting 
with unilateral symptoms. Mean CRP level was 34 mg/l (range 2–121, n=59) and 
mean blood leucocyte count 10.2 E9/l (range 3.5–21, n=53). Oral antibiotics were 
prescribed for 78% (104 of 133) of the children and 15% (16 of 104) of them were 
treated intravenously because of suspicion of a severe infection.
In Study I, 12 children (29%) had experienced a previous episode of parotitis 
(2–13 episodes, median 4), and 2 (4.8%) had had prolonged (30 and 45 days) 
intermittent parotid symptoms. A year after the end of recruitment for the study, the 
Table 4a. Characteristics of 41 children with acute parotitis.
Age
Years
Duration of
symptoms
Days
Temperature 
°C
Fever ≥ 38°C
Blood 
Leukocyte 
count E9/l
Normal 
range
4.5–13 E9/l
C-reactive
protein mg/l
Normal 
range
< 5 mg/l
Serum
Amylase U/l
Normal 
range
30–110 U/l
n=38
Median 6.2 2.0 37.2 11.1 13 261
Range 2.0–17 0.5–7.0 35.5–39.2 5.0–20.8 5.0–170 24–1220
Raised 
value (%) – – 17 (41) 11 (27) 28 (68) 30 (79)
Table 4b. Characteristics of patients treated with antibiotics and without antibiotics.
Children treated with 
antibiotics
N=20
Children treated without 
antibiotics
N=21
Temperature °C
Range (median)
Number of patients with 
temperature ≥ 38°C [%]
37.0–39.0 (38.0)
11 [55]
35.5–39.2 (37)
6 [29]
Blood Leukocyte count E9/l
Normal range 4.5–13 E9/l
Range (median)
Raised value [%]
6.8–20.8 (12.6)
8 [40]
5.0–15.5 (9.1)
3 [5]
C-reactive protein mg/l
Normal range < 5 mg/l
Range (median)
Raised value [%]
5.0–170 (43.5)
17 [85]
5.0–63 (9)
11 [55]
Serum Amylase U/l, n=19
Normal range 30–110 U/l
Range (median)
Raised value [%]
24–1114 (273)
15 [79]
40–1220 (256)
15 [79]
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children who were included during a primary episode of parotitis were telephoned 
for follow-up data. Of the 22 (76%) reached, 5 (23%) had had a recurrent parotitis. 
Thus, in Study I, the recurrent parotitis involved 19 (46%). In Study II, recurrent 
symptoms occurred in 57% (76 of 133) of the cases, of whom about half (38 of 76) 
had had four or more episodes of parotitis. Young age at the fi rst episode of parotitis 
indicated increased likelihood of a reoccurrence (p<0.0001). In Study I, the total 
follow-up time from the fi rst episode ranged from 1 to 6 years, comparable to those 
with no recurrences in Study II. In Study II, the mean follow-up ranged from 0.7–15 
years being 5.7 years for those with only one parotitis episode signifi cantly longer 
for those with recurrent symptoms (mean 7.0 years). 
5.2 Epidemiology (I)
Of the 728 (73%) children (358 boys) returning the epidemiologic survey, 64 (8.8%) 
reported a chronic illness requiring medication, and 714 (98%) claimed that they 
were vaccinated against mumps.
Of the respondents, 14 children (1.9%, 5 boys) reported having experienced 
parotitis, and 5 (0.7%, 1 boy) of them reported recurrent symptoms. All these children 
claimed that they were vaccinated against mumps. However, of the 14 children, 6 
had not seen a physician for their parotid symptoms, and therefore the accuracy of 
the diagnosis is questionable. Thus, of the 728 children, 8 (1.1%) in this survey had 
had a verifi ed parotitis. Of the 5 reporting recurrent symptoms, 3 children reported 
two episodes of parotitis, 1 reported three episodes and 1 reported ten episodes. 
Twenty-three children (3.2%) named a fi rst-degree family member with symptoms 
suggestive to parotitis but only 1 of these 23 children had himself-experienced 
parotid symptoms. 
5.3 Heredity of juvenile parotitis (I and II)
In Study I, of the 41 children, 1 girl (2%) with recurrent symptoms was positive 
for the N35S SPINK-1 mutation, and 2 children (5%) had a close family member 
with a history of parotitis. In Study II, 47 of 133 patients agreed to testing of the 
SPINK-1 genotype. Of these 47 children, 3 had a heterozygous N34S mutation, 
and 1 had a heterozygous P55S mutation. Thus, 8.5% of the tested children had a 
SPINK-1 mutation, which made them not signifi cantly different from the control 
group. Among controls were two N34S mutations in 39 children. In Study II, the 
questionnaire about parotitis, parotid-related symptoms, and parotitis in the close 
family was returned by 67% (89 of 133) of the families. Of these families 22% 
reported parotid-related symptoms in the close family, whereas the families of the 
controls signifi cantly less frequently reported parotid symptoms.
42
5 Results
5.4 Human herpesviruses in acute parotitis (III)
All 35 samples from the children with acute parotitis were positive for HHVs. HHV-6 
was identifi ed in 34 (97%) samples, of which 32 were positive for HHV-6B, 1 was 
positive for both HHV-6A and HHV-6B, and 1 for HHV-6A alone; 29 (83%) samples 
contained multiple herpesviruses, with 14 (40%) cases being double detection of 
HHV-6B plus HHV-7; 9 (26%) samples gave triple detection of HHV-6B and HHV-7 
plus either EBV or VZV or HSV-1; and 2 (6%) samples had four herpesviruses: 
HHV-6B, EBV, and CMV plus either HHV-7 or VZV. 
Of the 34 samples from the control children, 97% were positive for HHVs, 
with HHV-6 the most frequent fi nding. HHV-6B appeared in 28 (82%) samples 
(difference from patients non-signifi cant, Fisher’s exact test) but HHV-6A only 
in 1; 23 (68%) samples contained HHV-6 and some additional herpesvirus(es) 
(difference from patients non-signifi cant, Fisher’s exact test). The majority of the 
fi ndings were double detection of HHV-6B plus HHV-7 (21%) or HHV-6B plus 
EBV (17%). In addition, in 5 (15%) samples, three or four various herpesviruses 
occurred simultaneously. In 7 (21%) samples, only one virus, HVV-6 or HVV-7, 
was identifi ed.
Of the 10 adult samples, all were positive for herpesviruses. HHV-6 appeared 
less frequently than in the children with acute parotitis (p-value<0.05, Fisher’s 
exact test). Multiple HHVs including EBV and HSV-1 occurred in 9 (90%) samples 
(difference from patients non-signifi cant, Fisher’s exact test). In 1 sample, HHV-7 
was the only fi nding. VZV was undetected in any of the control samples. 
5.5 Diff erential diagnosis (IV)
The database search provided 6 children (aged 5–17 years, 1 boy) presenting with 
mandibular osteomyelitis initially diagnosed as recurrent parotitis over a period 
of 12 years. All the children had a primary diagnosis of JRP; the data-base search 
with osteomyelitis as a primary diagnosis provided negative results.
Each child had had an acute onset of symptoms, after which each had developed 
recurrent swelling and pain in the parotid region. They had received short courses 
of antibiotics and NSAIDs for any recurrent symptoms. The fi rst symptoms had 
occurred at a mean age of 9.5 years (range 5–13, median 11). A US investigation 
during one acute phase had shown no clear signs of parotid infl ammation. MRI 
led to the correct diagnosis, revealing edema and chronic changes in the bone 
structure typical for osteomyelitis. All children practiced good dental hygiene, and 
their general health was excellent.
The diagnostic delay for osteomyelitis ranged from 1.5 months to 6 years (mean 
24 months). The mean duration of symptoms after the correct diagnosis was 18.5 
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months (range 3 months to 4 years), and mean follow-up was 37 months (range 6 
months to 4 years). Blood leukocyte count was within normal limits in every case, 
CRP levels ranged from 3 to 30 mg/l and erythrocyte sedimentation rates were 
from 6 to 28 mm/h.
One child had multifocal disease affecting both the mandible and the ipsilateral 
clavicle. In all cases, a biopsy was taken for histological evaluation and bacterial 
culture. Two cases required debridement, and four children each had one wisdom 
tooth on the affected side removed (Table 5).
In three cases, Actinomyces was cultured from a bone sample, and in one case 
the culture showed structures resembling actinomyces. In addition, Streptococcus 
viridans occurred in three cases and Fusobacterium in one case. Four cases had 
more than one pathogen, and in two, bacterial cultures were negative (Table 5). 
All children received lengthy antibiotic treatment. In addition, two children with 
severe disease received hyperbaric oxygen treatment, which, however, had no clinical 
effect on the disease course. 
One boy suffered a relapse after a 6-month symptom-free period, and 
bisphosphonates were introduced to his treatment, producing promising preliminary 
results by 6 months. All children, except this one boy, have been symptom-free 
during follow-up (range 6 months to 4 years, median 37 months). Three patients 
are considered cured, since they have been symptom-free for over two years. 
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Table 5. Characteristics of six children with osteomyelitis ﬁ rst diagnosed as recurrent juvenile parotitis.
Patient
Age 
years/ 
Gender
Duration of 
symptoms 
before / after 
diagnosis 
m=months, 
y=years
Bacteriology
Tooth 
removal / 
Debridement
Antibiotic therapy 
after diagnosis 
of osteomelitis 
m=month
Follow-up / 
Outcome
m=months, 
y=years
1 5/F 2.5 y / 6 m
Actinomyces, 
Fusobacterium, 
Streptococcus 
viridans
No / No Penicillin 3 m 6 m / Symptom-free
2 11/F 18 m / 3 m
Actinomyces 
turicencis, 
Fuco-bacterium, 
Streptococcus 
viridans
d38 / No Penicillin 3 m
10 m / Symptom-
free, mouth-
opening mildly 
reduced
*3 13/M 1.5 m / 4 y
Actinomyces, 
Enterococcus 
faecalis, Candida 
albicans
d38 / Yes
Penicillin 3 m, 
amoxicillin + 
ﬂ ukonazole 4 m, 
meropenem
4 y / Symptoms 
persist
4 17/F 6 y / 5 m
Actinomyces 
type of bacteria, 
Propionibacterium 
acnes, 
Streptococcus 
viridans and 
anginosus
d38 / No Amoxicillin 40 days 24 m / Cured
5 10/F 12 m / 24 m Negative cultures No / No
Ciproﬂ oxacin and 
rifampicin 2 m, 
ciproﬂ oxacin 3 m
6 y / Cured
*6 11/F 10 m / 25 m Negative cultures d38 / Yes
Clindamycin + 
cephalexin 3 m, 
rifampicin and 
levoﬂ oxacin 2 m
5 y / Cured
*Children who received hyberbaric oxygen (HBO) in addition to other treatment.
5.6 Complications (V)
Records for 10 children (median age 10 years, range 2.2–16.8, 5 boys) suffering 
from a parotid abscess during a 10-year time-period were retrieved. This indicates 
an annual incidence of 0.067 cases per 100 000 inhabitants aged ≤17 (Table 6). 
Four children had suffered from parotitis or parotid-related symptoms during the 
preceding 6 to 24 months. One girl had suffered from a single episode of parotitis, one 
boy and one girl had had recurrent parotitis within 2 previous years, and another boy 
had a history of mild swellings of the parotid region without detailed diagnosis. 
All patients had similar symptoms prior to admission: mild to moderate fever, 
swelling of the parotid region, cellulites, and pain. None had bilateral symptoms 
or symptoms of septic infection nor had any history of oral pathology. The general 
health of all patients was good.
Two girls (aged 2.2 and 5.9) were diagnosed with fi rst brachial cleft cysts and 
later underwent superfi cial parotidectomy; one of these two had a recurrence of 
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a cyst infection before the operation. None of the others had any recurrence of 
an abscess during follow-up. However, one boy who had suffered from recurrent 
parotitis prior to the abscess had two mild parotid infections afterwards as well.
All children had received per oral antibiotic treatment before hospitalization 
and bacterial culture. Duration of antibiotic treatment ranged from 7 to 15 days, 
and 8 children developed the abscess during the treatment and 2 just after. 
Bacterial cultures were positive for Haemophilus infl uenzae (n=3), and one each 
for Streptococcus pneumonia, Proteus mirabilis, and Mycobacterium tuberculosis. 
In three, bacterial culture was negative, and for one, no culture was performed 
(Table 6).
The girl with Mycobacterium tuberculosis infection was of African origin. 
She developed a large parotid abscess, which, when needle aspirated twice under 
ultrasound guidance, yielded 20 ml and 40 ml of pus. A surgical incision was made 
as well, but she did not react as expected to the surgical and antibiotic treatment. 
A pus-sample culture fi nally revealed Mycobacterium tuberculosis. Her infection 
had affected her lungs, as well. She recovered well whit proper treatment.
In nine cases US was the initial diagnostic method, and in one case MRI. In 
seven cases, the abscess was drained, and three experienced spontaneous rupture. 
Two girls each had a fi stula formed after spontaneous rupture, with frequent 
secretion from it. Both girls were diagnosed with a fi rst branchial cleft anomaly, 
and treated with superfi cial parotidectomy later. Needle aspiration guided by US 
in four cases drained the abscess. In two cases, a surgical incision was required 
before the permanent cure. All surgical procedures were performed under general 
anesthesia and did not lead to fi stula formation. There occurred no need for more 
radical surgery in the acute phase. 
In addition to drainage, all patients received broad-spectrum intravenous 
antibiotic therapy. In most cases, antibiotics comprised a combination of 
metronidazole with penicillin or cefuroxime. Length of hospitalization ranged 
from 2 to 9 days, median 5.4. All children were symptom-free after a few months 
except for the two girls with fi rst brachial cleft fi stulas.
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6 DISCUSSION
Pediatric parotitis not associated with mumps is a rare disease, and most studies 
dealing with it comprise small numbers of patients, are retrospective, and lack 
control groups. There are many case reports based on which, not many conclusion 
can be made. The number of recent (2000–2012) papers in English on pediatric 
parotitis other than mumps is only 56. This study comprised a relatively large group 
of 41 pediatric parotitis patients, and assessed them systematically. The retrospective 
study comprised an even larger group of 133 children.
6.1 Clinical picture of juvenile parotitis
The clinical picture of juvenile parotitis in this study featured viral infection in 
most cases: the overall condition of these children was good, the bare majority 
had no fever and there was no purulent excretion from the parotid duct. Most of 
the patients had low blood leukocyte values as well. Whereas Stong et al. (2006) 
reported leukocytosis in 46% of their patients, in the present study leukocytosis 
was found in only 27% of the patients. In the acute phase, the CRP elevation was 
more frequent, but high values were rare. In Study II, leukocyte and CRP values 
were usually only moderately elevated. Determination of the serum amylase value 
served as an additional tool in the diagnostic work-up in Study I, since 79% of the 
patients showed an elevated value. For some reason, amylase is often forgotten in 
clinical work, even though in acute parotid infl ammation it rises (Scully et al., 1981, 
Ericson and Sjoback, 1996b,). 
Half the children in Study I received symptomatic treatment only, and had an 
excellent outcome, supporting the fact that antibiotics should not be an automatic 
part of treatment; the recommended treatment of parotitis has traditionally 
included antibiotics even with little evidence of their benefi t (Isaacs, 2002). In 
this study the infection parameters were somewhat lower in those children treated 
symptomatically (Table 4b), but based on this, it is impossible to state precise 
norms as to when symptomatic treatment is adequate. The most conservative 
approach towards antibiotics is wise in frequent episodes of JRP, the other end 
of the spectrum being neonates suffering from parotitis, as well as children with 
purulent secretion from their parotid duct who always require intensive treatment. 
In many cases, diagnosis can be based on the typical clinical picture and elevated 
serum amylase, but ultrasound is of assistance, especially if the diagnosis is unclear 
or a complication is suspected. 
Only 17 of 22 children and 20 of 35 control children had in their saliva detectable 
levels of IgG-type mumps antibodies, even though all children were assumed to be 
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vaccinated against mumps. The mumps vaccine virus is the weakest immunogen of 
the MMR vaccine components, so antibody formation may result in low antibody 
levels (Davidkin et al., 1995). In addition, antibody levels wane over time, and in 
general, total IgG antibody levels in saliva are lower than in serum. However, none 
of the children had high levels of IgM antibodies, suggesting that there were no acute 
mumps infections among these children. In any case, mumps must be included in 
the differential diagnosis since it is still endemic in many places, with outbreaks 
reported among vaccinated populations (Kancherla and Hanson, 2006). Of the 
respondents to the epidemiological study, 98% reported being vaccinated against 
mumps (MMR), which represents a high national vaccination coverage (Dorell et 
al., 2011, Vandermeulen et al., 2008).
In clinical evaluation, the possibility of another underlying disorder has to be 
kept in mind. Stong et al. (2005) found a relevant co-morbidity in 7 (33%) of their 
21 parotid patients, whereas in our study only one child had a predisposing co-
morbidity. Parotid gland enlargement is associated with such conditions as HIV 
infection, occurring in up to 10% of these patents. Typically, benign lymphoepithelial 
cysts are found in HIV-associated parotid gland enlargement (Dave et al., 2007). 
In our series, one boy who presented with repeated parotid swelling was later 
diagnosed as HIV-positive. However, he did not present with the typical fi ndings 
of lymphoepithelial cyst related to HIV, and his symptoms were basically unilateral. 
Therefore, the suspicion of HIV did not rise, and his diagnosis was delayed. Since the 
incidence of HIV has increased, the possibility of HIV even in a pediatric population 
must be remembered.
6.2 Epidemiological speculations
According to the epidemiological study, eight (1.1%) of 728 adolescents had had 
a parotitis with verifi ed diagnosis. In addition, six others claimed having suffered 
from parotitis-type symptoms. Thus, the frequency of juvenile parotitis may possibly 
reach 1.9% (range 1.1–1.9%). Of these 14 adolescents in total, fi ve reported recurrent 
symptoms. This is in line with the results of Studies I and II, which show recurrences 
in nearly half the cases. According to Study II, early onset of symptoms raises 
the likelihood of reoccurrences. The literature has no clear reports on recurrence 
frequency. In this study, no clear predisposing factor (clinical, laboratory or imaging 
fi ndings studied) was found that could predict recurrence. It can thus be concluded 
that pediatric parotitis seems not to be so rare after all, and reoccurrences are 
common. 
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6.3 Heredity of juvenile parotitis – anything new?
Since mutations of the SPINK-1 gene may predispose to juvenile pancreatitis 
(Drenth et al., 2002), and since the structure and function of salivary glands bear 
a resemblance to the pancreas, this study speculated the possible role of SPINK-1 
mutations in recurrent juvenile parotitis. However, only one child (2.0%) with acute 
parotid symptoms in Study I, and four (8.5%) in Study II with parotid symptoms 
were found to be positive for a N34S or P55S mutation. These fi ndings were not 
statistically signifi cant. Studies shown that 2.6% of Finnish blood donors are positive 
to N34S mutation and 1.3% to P55S (Lempinen et al., 2005), and in our control 
group 5.1% of the children were positive for either of these mutations. The number 
of children in this study is, however, too small for defi nitive genetic evaluation.
None of the children in Study I reported a history of parotitis in close family 
members, but interestingly, in Study II, 22% of the respondents did. Therefore, 
possible heredity of JRP deserves further study.
6.4 Have herpesviruses a role in juvenile parotitis?
The role of HHVs in pediatric parotitis arouses speculation, with some evidence as to 
their involvement (Davidkin et al., 2005). Nonetheless, the present study was unable 
to show signifi cant differences in HHV occurrence in the saliva of children with acute 
symptomatic parotitis compared with that in healthy children or adults. However, 
what was unexpected was that HHVs are indeed frequently present in saliva. HHVs 
were detectable from almost every saliva sample; even from asymptomatic subjects, 
and in many cases multiple viruses were evident. The only statistically signifi cant 
difference between the study groups was that children’s saliva seemed more often 
to contain HHV-6 than did adults’.
HHV-6 is known to infect children, the primary infection and reactivation 
possibly both being asymptomatic (Caserta et al., 2004, Zerr et al., 2005). HHV-6 
was a common fi nding in both the pediatric parotitis group (97%) and the pediatric 
control group (82%), and seemed not to associate with parotitis symptoms. In adults, 
HHV-6 occurred in the majority (60%) of the samples as well, but statistically was 
less common in adults than in children. HHV-7 was also a frequent fi nding in all 
three groups. VZV appeared in 5.7% of the children with acute parotitis but in none 
of the control samples. However, that the difference in VZV was not statistically 
signifi cant may relate to the relatively low number of subjects.
HSV-1 is present in the saliva of asymptomatic children and adults as a result 
of occasional viral reactivation (Spicher et al., 2001, Liljeqvist et al., 2009). The 
fi ndings of this study supported this with HSV-1 in 2.8% of pediatric parotitis, in 
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8.8% of pediatric controls, and in 10% of adult controls. HSV-2, on the other hand, 
not being a respiratory tract pathogen, was predictably absent from all samples. 
In addition to respiratory tract infections and mucosal lesions, EBV has been 
associated with periodontitis in adults, (Slots et al., 2006) and is therefore an 
important pathogen in oral diseases. Davidkin et al. (2005) found elevated IgG 
and IgM antibodies to EBV in 7% of their 601 pediatric patients with mumps-
like symptoms. The present study was unable to show any statistically signifi cant 
difference in EBV rates between the parotitis and control groups. 
Even though this study was unable to show any relation between HHVs and 
parotitis, it can be speculated that perhaps the primary HHV infection presents as 
parotitis whereas reactivation does not. Most children suffer from HHV-6 infection 
by the age of two (Zerr et al., 2005), earlier than the fi rst peak onset of parotitis 
(Study II). On the other hand, VZV infects children at approximately that same 
age. In this study VZV appeared in few parotid patients but in none of the control 
patients. Most children are infected by EBV by the age of 12, which is approximately 
the time after which juvenile parotitis becomes rare (Study II).
6.5 The importance of osteomyelitis in diff erential diagnosis
Acute osteomyelitis is a potentially life-threatening disease. Recurrent juvenile 
parotitis, on the other hand, is a benign condition usually resolving after puberty. 
In these series, although their ultrasound tests were negative in the acute or subacute 
phase of parotid swelling, all children received the diagnosis of JRP. Based on this 
experience, MRI should be scheduled for children whose diagnosis of JRP has not 
been verifi ed. The diagnosis of primary parotitis may be clinical. 
There were fi ve female cases of osteomyelitis in this study even though male 
predominance has been reported (Weichert et al., 2008). Symptoms of osteomyelitis 
seemed to occur in the prepubertal years, somewhat later than the typical onset of 
JRP (Study I and II). An unerupted wisdom tooth was suspected to be the origin of 
the osteomyelitis in two cases, whereas the other cases had no clear predisposing 
factor. Overall prognosis was good, as after a mean follow-up of 37 months, fi ve of 
six children were symptom-free. Altogether, the symptoms of the children in this 
study are suggestive of a primary chronic form of osteomyelitis (Baltensperger et 
al., 2004) rather than acute osteomyelitis: the overall condition of the children 
was good, and infection parameters were low. In osteomyelitis, symptoms of the 
infected area tend to be sustained over time, whereas in JRP the child is completely 
symptom-free between periods of swelling.
Few papers report on actinomycosis in children. Here three of the six children 
who underwent biopsies were culture-positive for Actinomyces known to be a 
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causative agent in osteomyelitis (Robinson et al., 2005, Stewart et al., 2005), and 
in this study it was also the most common bacterium. However, according to the 
literature the most common causative agent is Staphylococcus aureus (Vinod et 
al., 2002), and therefore the antibiotics chosen, as fi rst-line treatment should cover 
this pathogen. Streptococci and gram-negative bacteria, as well, are encountered. 
A sample for bacteriology should be obtained, when possible. In addition to 
conventional therapy, two of the six children were treated with adjuvant HBO 
therapy with disappointing results. Others have reported more benefi cial results 
from HBO treatment in osteomyelitis (Aitasalo et al., 1998, Lentrodt et al., 2007). 
Since osteomyelitis is a rare entity, the number of subjects in studies is bound to 
be low, making it diffi cult to reach a consensus on treatment of choice.
Another recent adjuvant therapy for osteomyelitis with promising results 
involves bisphosphonates (Gleeson et al., 2008, Simm et al., 2008, Landesberg et 
al., 2009). One child in Study IV, with persistent recurrent symptoms received three 
pamidronate infusions as an adjunct therapy with promising preliminary results. It 
is still too early to evaluate the fi nal outcome. The role of bisphosphonates in the 
treatment of diffi cult osteomyelitis is most likely going to expand, but again, since 
osteomyelitis is a rare entity, gaining solid data is diffi cult.
Based on this study, osteomyelitis is defi nitely highly important in the differential 
diagnosis of JRP. 
6.6 Parotid abscess – a rare complication 
Parotid abscesses represent only a small portion of parotid infections. Ten children 
with an abscess during a ten-year period were traced. Four of them had suffered 
from a previous parotitis or from parotid-related symptoms. One of them had a 
single episode of parotid infl ammation, whereas the others had recurrent parotid 
symptoms. This supports the fact that a parotid abscess can emerge without other 
salivary gland pathology. On the other hand, what must be remembered is that 
other pathologies of the region may dispose to abscess formation. In this study, two 
girls had fi rst branchial cleft cysts and later underwent superfi cial parotidectomy. 
First brachial cleft cyst is a low-incidence anomaly that can lead to fi stula formation 
and result in frequent suppuration of the parotid gland. A permanent cure requires 
surgical treatment (Triglia et al., 1998). 
All ten children had received per oral antibiotic treatment before hospitalization 
and bacterial culture. Eight developed the abscess during treatment, and two 
children a few days afterwards. Of fi ve positive bacterial cultures, four showed 
common pathogens, and Mycobacterium tuberculosis appeared in one. When 
treating infections not responding to treatment as expected to, the possibility of 
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tuberculosis must be kept in mind, even though tuberculosis of the parotid gland is 
rare, even where the disease is endemic. The girl with Mycobacterium tuberculosis 
infection in Study V was originally from an endemic region. The possibility of HIV 
infection behind parotid symptoms must also be kept in mind.
When an abscess has formed, surgical drainage is considered necessary (Brook, 
2003). Methods include quite radical procedures such as multiple drainage incisions 
or raising a full posterior-based fl ap as for parotidectomy. But it seems that in 
most cases quite a small procedure is suffi cient (Ganesh and Leese, 2005). None 
of this study’s patients needed radical drainage procedures, which may lead to poor 
wound healing, saliva fi stula formation, and poor cosmetic outcome and therefore 
should be avoided. 
Facial nerve paresis has been reported in relation to parotid abscesses (Smith 
and Hartig, 1997) in adults. None of the children developed facial nerve dysfunction 
due to either the infection or surgery. Spread of a parotid infection may cause severe 
complications (Marioni et al., 2003, Kishore et al., 2004) such as mediastinitis, but 
luckily the present series included no mediastinitis nor other spread of infection. 
6.7 Future aspects
The causative agents of acute pediatric parotitis or JRP are unclear. A possible viral 
involvement in acute parotitis especially deserves future research. On the other hand, 
the factors possibly predisposing to JRP would be interesting to reveal. Treatment 
of JRP is defi nitely worth future study since, although the disease is usually self-
limiting, the frequent symptoms can be life-disruptive. It will, however, be somewhat 
challenging to collect a suffi ciently large controlled study group for a prospective 
treatment trial. 
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7 CONCLUSIONS
1. Juvenile parotitis shows a frequency of about 1%, and the parotid 
symptoms have a tendency to recur in almost half the cases. In many 
cases, the episodes of parotitis in childhood are isolated symptoms 
in the parotid area with a benign course not necessitating antibiotic 
therapy.
2. This study found no correlation between SPINK-1 mutations and 
juvenile parotitis. 
3. Human herpesviruses (HHVs) are frequent fi ndings in saliva but seem 
to play no role in juvenile parotitis. 
4. Mandibular osteomyelitis may present with similar symptoms to those 
of juvenile recurrent parotitis, and is therefore important in differential 
diagnosis.
5. Parotid abscesses in children are multi-bacterial infections not 
necessarily related to other parotid gland pathologies. Intravenous 
antibiotic therapy is the cornerstone of the treatment, but surgical 
drainage assists in recovery and should not lead to fi stula formation.
6. Serum amylase is frequently elevated in acute parotitis and is a useful 
diagnostic tool in clinical work.
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